Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1


  1. Durrheim, D. N. et al. A dangerous measles future looms beyond the COVID-19 pandemic. Nat. Med. 27, 360–361 (2021).

  2. Hashiguchi, T. et al. Structures of the prefusion form of measles virus fusion protein in complex with inhibitors. Proc. Natl Acad. Sci. USA 115, 2496–2501 (2018).

    Article  CAS  Google Scholar 

  3. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893–897 (2000).

    Article  CAS  Google Scholar 

  4. Chang, A. & Dutch, R. E. Paramyxovirus fusion and entry: multiple paths to a common end. Viruses 4, 613–636 (2012).

    Article  CAS  Google Scholar 

  5. Harrison, S. C. Viral membrane fusion. Nat. Struct. Mol. Biol. 15, 690–698 (2008).

    Article  CAS  Google Scholar 

  6. Welsch, J. C. et al. Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J. Virol. 87, 13785–13794 (2013).

    Article  CAS  Google Scholar 

  7. Malvoisin, E. & Wild, F. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J. Virol. 64, 5160–5162 (1990).

    Article  CAS  Google Scholar 

  8. Fayolle, J., Verrier, B., Buckland, R. & Wild, T. F. Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization. J. Virol. 73, 787–790 (1999).

    Article  CAS  Google Scholar 

  9. Avila, M. et al. Molecular determinants defining the triggering range of prefusion F complexes of canine distemper virus. J. Virol. 88, 2951–2966 (2014).

    Article  Google Scholar 

  10. Czuppon, P. et al. Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action. PLoS Comput Biol. 17, e1008752 (2021).

    Article  CAS  Google Scholar 

Download references


We thank J. S. Orange and S. G. Kernie for their contributions to this study.


The work was supported by grants from the NIH: AI121349, NS091263, and NS105699, AI146980 to M.P., from the French ANR NITRODEP (ANR-13-PDOC-0010-01) to C.M. and from the Region Auvergne Rhone Alpes and LABEX ECOFECT (ANR-11-LABX-0048) of Lyon University within the program “Investissements d'Avenir” (ANR-11-IDEX-0007), operated by the French National Research Agency (ANR) to B.H. The Sharon Golub Fund at Columbia University Irving Medical Center (CUIMC).

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Cyrille Mathieu or Matteo Porotto.

Ethics declarations

Competing interests

C.M., A.M., B.H., and M.P. have submitted a provisional on the use of the scFv.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mathieu, C., Ferren, M., Harder, O. et al. Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo. Cell Mol Immunol 18, 1835–1837 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links